Alliance for Safe Biologic Medicines
The Alliance for Safe Biologic Medicines is an organization composed of diverse healthcare groups and individuals—from patients to physicians, biotechnology companies that develop innovative and biosimilar medicines and others who are working together to ensure patient safety is at the forefront of the biosimilars policy discussion. With more than 60 members spread across five continents, we reflect a wide range of voices within the healthcare community. Our coalition strives to position itself to be an authoritative resource center of information for the healthcare and policy communities.